A Duplex qPCR Assay Targeting the fadA Gene Enables Robust Detection of Fusobacterium in Clinical Samples
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311319 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yurin Seo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of …. Hauptthemen laut MEDLINE: Real-Time Polymerase Chain Reaction, Adhesins, Bacterial, Fusobacterium Infections, Fusobacterium nucleatum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare,…, the Bio & Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MSIT), the "Hankookilbo Myung-Ho Seung" Faculty Research Assistance Program of Yonsei University College of Medicine.
Abstract (Originalsprache)
Fusobacterium nucleatum (Fn) is increasingly recognized as a cancer-associated bacterium, yet reliable quantification in human specimens is challenging due to low bacterial burden and abundant host DNA. We analyzed 145 Fusobacterium genomes to design primers targeting conserved regions of the fadA adhesin gene and developed a duplex quantitative real-time PCR (qPCR) assay for simultaneous detection of fadA and a human PGT as an internal control. Analytical sensitivity, specificity, precision, and reproducibility were evaluated using serially diluted Fn DNA, spike-in experiments with human DNA, and cross-platform/operator validation. Clinical performance was assessed in colorectal cancer patient tissues, including fresh tissue (n = 24) and formalin-fixed paraffin-embedded (FFPE) samples (n = 22), using 16S rRNA-based methods as references. The assay successfully detected all four major Fn subspecies (nucleatum, animalis, polymorphum, and vincentii). The limit of detection was ≤0.1 pg, with no interference between duplex targets. Spike-in experiments demonstrated consistent target detection in human-DNA-rich samples, with strong linearity (R2 = 0.998) across dilutions. High precision (coefficient of variations < 5%) was observed across intra-day, inter-day, inter-instrument, and inter-operator evaluations. In fresh tissues, the assay yielded 86% sensitivity, 94% specificity, and 92% accuracy. Using the FFPE samples, the assay achieved 91% sensitivity and 100% specificity, confirming robust classification in both clinical samples. This duplex qPCR assay enables broad detection of Fn with high analytical performance in both fresh and FFPE tissues. Its simplicity, reproducibility, and compatibility with pathology workflows support deployment in multi-center studies and downstream applications in diagnostic studies and prognostic modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Graduate School of Medical Science, Brain Korea 21 FOUR Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- School of Medicine, Georgetown University, Washington, DC 20007, USA.
- Center for Natural Product Efficacy Optimization, Korea Institute of Science and Technology (KIST), Gangneung 25451, Republic of Korea.
- Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Kyung-A Kim, Yura Seo, Francesca Jereis, Yoon Dae Han, Hyukmin Lee, Jihoon G Yoon, Han Sang Kim
Förderung
- a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare,…
- the Bio & Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MSIT)
- the "Hankookilbo Myung-Ho Seung" Faculty Research Assistance Program of Yonsei University College of Medicine
- a faculty research grant of Yonsei University College of Medicine
- the Technology Innovation Program
- a research grant funded by the CKDBiO-YONSEI Microbiome Research Center (CYMRC)
- The National Research Foundation (NRF) funded by the Korea government (MSIT)
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Seo, Y., Kim, K. A., Lee, S., Lim, Y. H., Seo, Y., Kim, T. K., Kim, C. H., Kim, Y., Jereis, F., Kim, W. K., Han, Y. D., Jung, M., Lee, H., Lee, K., Ahn, J. B., Yoon, J. G., & Kim, H. S. (2025). A Duplex qPCR Assay Targeting the fadA Gene Enables Robust Detection of Fusobacterium in Clinical Samples. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311319
Vancouver
Seo Y, Kim KA, Lee S, Lim YH, Seo Y, Kim TK, et al. A Duplex qPCR Assay Targeting the fadA Gene Enables Robust Detection of Fusobacterium in Clinical Samples. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311319
BibTeX
@article{Seo2025,
author = {Seo, Yurin and Kim, Kyung-A and Lee, Suho and Lim, Yujin H and Seo, Yura and Kim, Taeyul K and Kim, Chae Hyun and Kim, Yeleem and Jereis, Francesca and Kim, Won Kyu and Han, Yoon Dae and Jung, Minsun and Lee, Hyukmin and Lee, Kyungwon and Ahn, Joong Bae and Yoon, Jihoon G and Kim, Han Sang},
title = {A Duplex qPCR Assay Targeting the fadA Gene Enables Robust Detection of Fusobacterium in Clinical Samples},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311319}
}
EUVIMED